Taking a longer term view of cardiovascular risk: the causal exposure paradigm.
Mike Rosenbloom Laboratory for Cardiovascular Research, McGill University Health Centre, Room H7.22, Royal Victoria Hospital, 687 Pine Avenue West, Montreal, QC H3A 1A1 Canada allansniderman@hotmail.com.
Allan D
AD
Sniderman
Department of Family and Community Medicine, University of Illinois School of Medicine, Peoria, IL.
Peter P
PP
Toth
CGH Medical Center, Sterling, IL, USA Cardiology Division, Department of Medicine, Royal Victoria Hospital, McGill University Health Centre, Montreal, Canada.
George
G
Thanassoulis
Duke Clinical Research Institute, Durham, NC, USA.
Michael J
MJ
Pencina
Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
Curt D
CD
Furberg
D000367:Age Factors; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D018570:Risk Assessment; D012307:Risk Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors